Clinical Trial Update: PaCIFiC-CUP Classifies Cancer of Unknown Primary

View source ↗

Summary

Clinical trial update indicating the PaCIFiC-CUP program is currently recruiting to classify cancer of unknown primary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer of Unknown Primary

Drugs mentioned

• PaCIFiC-CUP

Snippet

Sponsor: Sun Yat-sen University | Conditions: Unknown Primary Tumors, DNA Methylation | Status: RECRUITING